Ipsen Sa Adr Stock Performance
| IPSEY Stock | USD 34.94 0.25 0.71% |
Ipsen SA has a performance score of 7 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.51, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Ipsen SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ipsen SA is expected to be smaller as well. Ipsen SA ADR right now retains a risk of 1.61%. Please check out Ipsen SA jensen alpha, potential upside, as well as the relationship between the Potential Upside and daily balance of power , to decide if Ipsen SA will be following its current trending patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ipsen SA ADR are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Ipsen SA may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
Ipsen |
Ipsen SA Relative Risk vs. Return Landscape
If you would invest 3,202 in Ipsen SA ADR on September 26, 2025 and sell it today you would earn a total of 292.00 from holding Ipsen SA ADR or generate 9.12% return on investment over 90 days. Ipsen SA ADR is currently producing 0.149% returns and takes up 1.6088% volatility of returns over 90 trading days. Put another way, 14% of traded pink sheets are less volatile than Ipsen, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ipsen SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ipsen SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ipsen SA ADR, and traders can use it to determine the average amount a Ipsen SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0926
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IPSEY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Ipsen SA is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ipsen SA by adding it to a well-diversified portfolio.
Ipsen SA Fundamentals Growth
Ipsen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ipsen SA, and Ipsen SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ipsen Pink Sheet performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 8.28 B | |||
| Shares Outstanding | 330.56 M | |||
| Price To Earning | 14.23 X | |||
| Price To Book | 2.73 X | |||
| Price To Sales | 2.72 X | |||
| Revenue | 3.16 B | |||
| EBITDA | 1.06 B | |||
| Cash And Equivalents | 1.07 B | |||
| Cash Per Share | 3.24 X | |||
| Total Debt | 562.8 M | |||
| Debt To Equity | 0.38 % | |||
| Book Value Per Share | 10.13 X | |||
| Cash Flow From Operations | 971.4 M | |||
| Earnings Per Share | 1.92 X | |||
| Total Asset | 5.61 B | |||
About Ipsen SA Performance
Evaluating Ipsen SA's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ipsen SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ipsen SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen SA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4500 people.Things to note about Ipsen SA ADR performance evaluation
Checking the ongoing alerts about Ipsen SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ipsen SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Ipsen SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ipsen SA's pink sheet performance include:- Analyzing Ipsen SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ipsen SA's stock is overvalued or undervalued compared to its peers.
- Examining Ipsen SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ipsen SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ipsen SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ipsen SA's pink sheet. These opinions can provide insight into Ipsen SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Ipsen Pink Sheet Analysis
When running Ipsen SA's price analysis, check to measure Ipsen SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ipsen SA is operating at the current time. Most of Ipsen SA's value examination focuses on studying past and present price action to predict the probability of Ipsen SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ipsen SA's price. Additionally, you may evaluate how the addition of Ipsen SA to your portfolios can decrease your overall portfolio volatility.